Cargando…
Fluoroquinolones and Risk for Methicillin-Resistant Staphylococcus aureus, Canada
Receipt of fluoroquinolones was the predominant risk factor for Clostridium difficile–associated disease (CDAD) during an epidemic in Quebec, Canada. To determine the role of antimicrobial drugs in facilitating healthcare-associated methicillin-resistant Staphylococcus aureus (MRSA) colonization and...
Autores principales: | LeBlanc, Louiselle, Pépin, Jacques, Toulouse, Krystel, Ouellette, Marie-France, Coulombe, Marie-Andrée, Corriveau, Marie-Pier, Alary, Marie-Eve |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294753/ https://www.ncbi.nlm.nih.gov/pubmed/17073089 http://dx.doi.org/10.3201/eid1209.060397 |
Ejemplares similares
-
Fluoroquinolones and the Risk for Methicillin-resistant Staphylococcus aureus in Hospitalized Patients
por: Weber, Stephen G., et al.
Publicado: (2003) -
Fluoroquinolone Metalloantibiotics: A Promising Approach against Methicillin-Resistant Staphylococcus aureus
por: Ferreira, Mariana, et al.
Publicado: (2020) -
Community-associated Methicillin-resistant Staphylococcus aureus, Canada
por: Mulvey, Michael R., et al.
Publicado: (2005) -
Impact and benefit-cost ratio of a program for the management of latent tuberculosis infection among refugees in a region of Canada
por: Pépin, Jacques, et al.
Publicado: (2022) -
Comparing methods to estimate incremental inpatient costs and length of stay due to methicillin-resistant Staphylococcus aureus in Alberta, Canada
por: Kirwin, Erin, et al.
Publicado: (2019)